-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Initiates Coverage On Eikon Therapeutics with Overweight Rating

Benzinga·03/02/2026 18:49:09
Listen to the news
Cantor Fitzgerald analyst Imogen Mansfield initiates coverage on Eikon Therapeutics (NASDAQ:EIKN) with a Overweight rating.